Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 171

1.

Combination therapy for obesity and metabolic disease.

Gadde KM, Allison DB.

Curr Opin Endocrinol Diabetes Obes. 2009 Oct;16(5):353-8. doi: 10.1097/MED.0b013e3283304f90. Review.

PMID:
19625958
[PubMed - indexed for MEDLINE]
2.

Combination pharmaceutical therapies for obesity.

Gadde KM, Allison DB.

Expert Opin Pharmacother. 2009 Apr;10(6):921-5. doi: 10.1517/14656560902824152 .

PMID:
19351275
[PubMed - indexed for MEDLINE]
3.

Anti-obesity drugs.

Kushner RF.

Expert Opin Pharmacother. 2008 Jun;9(8):1339-50. doi: 10.1517/14656566.9.8.1339 . Review.

PMID:
18473708
[PubMed - indexed for MEDLINE]
4.

New drug targets for the treatment of obesity.

Powell AG, Apovian CM, Aronne LJ.

Clin Pharmacol Ther. 2011 Jul;90(1):40-51. doi: 10.1038/clpt.2011.82. Epub 2011 Jun 8. Review.

PMID:
21654742
[PubMed - indexed for MEDLINE]
5.

How physician obesity specialists use drugs to treat obesity.

Hendricks EJ, Rothman RB, Greenway FL.

Obesity (Silver Spring). 2009 Sep;17(9):1730-5. doi: 10.1038/oby.2009.69. Epub 2009 Mar 19.

PMID:
19300434
[PubMed - indexed for MEDLINE]
6.

Combination treatment to CONQUER obesity?

Shah K, Villareal DT.

Lancet. 2011 Apr 16;377(9774):1295-7. doi: 10.1016/S0140-6736(11)60518-7. No abstract available.

PMID:
21497686
[PubMed - indexed for MEDLINE]
7.

Targeting hyperglycaemia with anti-obesity drugs: time for a paradigm shift?

Krentz AJ, Hompesch M.

Drugs. 2013 Oct;73(15):1649-51. doi: 10.1007/s40265-013-0123-2. No abstract available.

PMID:
24092613
[PubMed - indexed for MEDLINE]
8.

FGF21: a novel prospect for the treatment of metabolic diseases.

Kharitonenkov A, Shanafelt AB.

Curr Opin Investig Drugs. 2009 Apr;10(4):359-64. Review.

PMID:
19337957
[PubMed - indexed for MEDLINE]
9.

New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases.

Shehzad A, Ha T, Subhan F, Lee YS.

Eur J Nutr. 2011 Apr;50(3):151-61. doi: 10.1007/s00394-011-0188-1. Epub 2011 Mar 27. Review.

PMID:
21442412
[PubMed - indexed for MEDLINE]
10.

Obesity pharmacotherapy from a regulatory perspective: overview and key challenges.

Hutchinson NI, Ryder SW.

Clin Pharmacol Ther. 2007 May;81(5):756-60. Epub 2007 Mar 28. Review.

PMID:
17392723
[PubMed - indexed for MEDLINE]
11.

Drug discovery in the metabolic syndrome: context and some recent developments.

Suckling K.

Expert Opin Ther Targets. 2007 Jun;11(6):801-8. Review.

PMID:
17504017
[PubMed - indexed for MEDLINE]
12.

A review of late-stage CNS drug candidates for the treatment of obesity.

Heal DJ, Gosden J, Smith SL.

Int J Obes (Lond). 2013 Jan;37(1):107-17. doi: 10.1038/ijo.2012.26. Epub 2012 Mar 13. Review.

PMID:
22410963
[PubMed - indexed for MEDLINE]
13.

Sibutramine: current status as an anti-obesity drug and its future perspectives.

Sharma B, Henderson DC.

Expert Opin Pharmacother. 2008 Aug;9(12):2161-73. doi: 10.1517/14656566.9.12.2161 . Review.

PMID:
18671470
[PubMed - indexed for MEDLINE]
14.

Lorcaserin and adiposopathy: 5-HT2c agonism as a treatment for 'sick fat' and metabolic disease.

Bays HE.

Expert Rev Cardiovasc Ther. 2009 Nov;7(11):1429-45. doi: 10.1586/erc.09.123. Review.

PMID:
19900026
[PubMed - indexed for MEDLINE]
15.

Treatment of overweight and obesity: lifestyle, pharmacologic, and surgical options.

Cannon CP, Kumar A.

Clin Cornerstone. 2009;9(4):55-68; discussion 69-71.

PMID:
19789064
[PubMed - indexed for MEDLINE]
16.

Pharmacotherapy of obesity: emerging drugs and targets.

Chakrabarti R.

Expert Opin Ther Targets. 2009 Feb;13(2):195-207. doi: 10.1517/14728220802637063 . Review.

PMID:
19236237
[PubMed - indexed for MEDLINE]
17.

Drug treatment of obesity: established and emerging therapies.

Isidro ML, Cordido F.

Mini Rev Med Chem. 2009 Jun;9(6):664-73. Review.

PMID:
19519492
[PubMed - indexed for MEDLINE]
18.

Drug evaluation: tagatose in the treatment of type 2 diabetes and obesity.

Moore MC.

Curr Opin Investig Drugs. 2006 Oct;7(10):924-35. Review.

PMID:
17086938
[PubMed - indexed for MEDLINE]
19.

Pharmacotherapy for psychotropic drug-related weight gain.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2008 Jul;46(7):15-8. Review.

PMID:
18686592
[PubMed - indexed for MEDLINE]
20.

Report on the NIH Workshop on Pharmacologic Treatment of Obesity.

Atkinson RL, Hubbard VS.

Am J Clin Nutr. 1994 Aug;60(2):153-6.

PMID:
7913290
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk